Teleflex swings to $(9.24) Q3 loss on $403.9M goodwill charge; cuts 2025 guidance
Teleflex reported third-quarter 2025 GAAP revenue of $913.0 million, up 19.4%, and a GAAP diluted loss of $(9.24) per share, compared with earnings of $2.36 a year earlier. The loss reflects a $403.9 million non-cash goodwill impairment on its Interventional Urology North America unit, and the company lowered its full-year 2025 GAAP EPS and adjusted constant currency revenue growth outlooks, which matters because the charges and cut weigh directly on reported results.
Key points
- Q3 GAAP revenue $913.0 million, up 19.4%; adjusted revenue $892.9 million, up 16.8%
- Q3 adjusted diluted EPS $3.67 versus $3.49 a year earlier; GAAP diluted EPS $(9.24) versus $2.36
- 2025 GAAP diluted EPS outlook lowered to $(4.42) to $(4.22) from $6.73 to $7.13; adjusted EPS narrowed to $14.00 to $14.20
- Adjusted constant currency revenue growth outlook lowered to 6.90% to 7.40% from 7.70% to 8.70%
The filing
Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.